Corxel Pharmaceuticals may not have always planned to dust off the special purpose acquisition company (SPAC) route to the ...

Boehringer Ingelheim and Microsoft have launched a collaboration to explore the use of AI-powered digital patient twins to improve clinical trial design. | Boehringer Ingelheim and Microsoft have ...

“If Powerful AI is directed at solving humanity’s hardest problems and the risks are managed responsibly, the potential is ...